THREAD Enriches Its Platform with CureClick to Accelerate Enrollment, Improve Diversity and Enhance the Patient Experience in Decentralized Clinical Trials
CARY, N.C., April 19, 2022 /PRNewswire/ -- THREAD®, a leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), today announced that it has acquired CureClick. Headquartered in Costa Mesa, Calif., CureClick offers the world's first proprietary crowdsourcing platform designed exclusively to accelerate awareness and participation in clinical research. CureClick follows THREAD's recent acquisitions of Modus Outcomes and inVibe, positioning THREAD as the industry's leading patient-centric provider of DCTs.
Pharmaceutical Partner
Started Here
“Other companies had the usual solutions to get full recruitment for our study. What CureClick offered was totally unique--and it worked.”
Oncology Ambassador
Started Here
“There’s nothing else like this out there. CureClick helped us spread the word about our trial in a truly organic way.”
7 YEARS
IN BUSINESS
6.5K
ACTIVE HEALTHCARE AMBASSADORS
450+
SUCCESSFUL RECRUITMENT CAMPAIGNS
77+
ACROSS
THERAPEUTIC
AREAS
100K+
PATIENT
LIVES CHANGED
10MM+
TRIAL
IMPRESSIONS
67+
SPONSORS
Neurological Disease Ambassador
Started Here
“I consider myself a passionate advocate. If there’s a clinical trial going on, I want to tell my community about it. I want to empower them with information. CureClick makes it so easy.”
Our ambassadors are leaders in online communities that serve as hubs of information for millions of patients. We have ambassadors representing, and advocating for hundreds of therapeutic areas, from rare to common, and everything in between.
With our platform, each ambassador has access to a private profile where they can get easy sharing tools. We package clinical study information into impactful images, and simple social media posts (eg, Facebook, Instagram) that they can use with their communities.
“Someone in my Facebook group shared a post from CureClick, and it had all the information I needed. I used to think clinical trials were so complicated, but CureClick made it really simple, and easy to understand.”
Parkinson’s patient
Started Here
We know patients see their online communities as lifelines, as one-stop-shops for the latest news, and information about their health conditions. We want to engage with them on their terms by partnering with the community leaders, and advocates they trust.